Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 4488-4492, August 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimura, N.
Right arrow Articles by Kikuchi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimura, N.
Right arrow Articles by Kikuchi, M.

Rearrangement of T-Cell Receptor {delta} Chain Gene as a Marker of Lineage and Clonality in T-Cell Lymphoproliferative Disorders1

Nobuhiro Kimura2, Yoshihiro Takihara, Tomi Akiyoshi, Takahisa Yoshida, Koichi Ohshima, Takashi Kawara, Shusuke Hisano, Mitsuo Kozuru, Makoto Okumura and Masahiro Kikuchi

First Department of Internal Medicine [N. K., T. A., T. K., S. H., M. O.] and The First Department of Pathology [T. Y., K. O., M. K.], Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-01, Japan; The Department of Biophysics, Ontario Cancer Institute, University of Toronto, Ontario, M4X 1K9, Canada; [Y. T.] and the Department of Hematology, National Kyushu Cancer Center Hospital, 3-1-1 Notame, Fukuoka 815, Japan [M. K.]

We analyzed the rearrangement of T-cell receptor (TcR) {delta} chain gene in 88 cases of lymphoproliferative disorders; 31 acute lymphoblastic leukemias/lymphoblastic lymphomas (ALL/LBL); 27 adult T-cell leukemias/lymphomas, 9 angioimmunoblastic lymphoadenopathies (AILD); 10 T-cell lymphomas (non-Hodgkin's lymphoma); and 11 Hodgkin's disease. All of 9 T-ALL/LBL cases, of which 4 cases have neither ß nor {gamma} gene rearrangement, had a new rearranged band of TcR {delta} locus. Ten of 16 B-lineage ALL/LBL had rearranged band(s) or deletion of TcR {delta} locus. The rearranged bands were recognized in 2 cases of AILD and 1 case of T-cell lymphoma. All cases of adult T-cell leukemias/lymphomas, 4 of AILD, 4 of T-cell lymphoma, and 8 of Hodgkin's disease had deleted TcR {delta} locus. Heterogeneous findings of TcR {delta} locus analysis were observed in AILD, T-cell lymphoma, and Hodgkin's disease. In 16 cases with TcR {delta} rearrangement, the J{delta}1 region was frequently used and the J{delta}2 region was rearranged in one AILD. It is suspected that J{delta}3 was used in one T-ALL/LBL. There was no correlation between the phenotypic pattern of CD3, CD4, CD8 in T-cell disorders and the rearrangement of the TcR {delta} gene. These findings suggest that the newly identified TcR {delta} chain gene rearranges at a very early stage of T-cell ontogeny; prior to the other TcR genes and perhaps at almost the same stage with CD7 expression. The TcR {delta} gene is useful in assessing clonality for the most immature T-cell neoplasms not showing rearrangement of the other TcR genes. This gene is not lineage specific; however, when used in conjunction with immunoglobulin heavy chain gene, it may be a useful tool to distinguish lymphoid lineage of ALL/LBL.

1 This work was supported in part by Grant-in-Aid for Scientific Research 63570579 from the Ministry of Education, Science and Culture, Japan, and by Grant 1567 from the Naito Foundation and Grant 63235 from the Fukuoka Anti-Cancer Society.

2 To whom requests for reprints should be addressed, at The First Department of Internal Medicine, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-01, Japan.

Received 2/14/89. Revised 5/ 8/89. Accepted 5/11/89.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.